Perrigo | PRGO - Current Liabilities


Perrigo reported $997.6M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AbbVie USD 42.1B 1.19B Mar/2026
Abbott USD 18.38B 1.88B Mar/2026
Bayer EUR 33.46B 875M Mar/2026
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
Coherus Biosciences USD 140.39M 231.91M Dec/2025
Corcept Therapeutics USD 149.18M 16.9M Mar/2026
Dr.Reddys Laboratories INR 167.47B 9.16B Mar/2026
Eli Lilly USD 36.63B 1.41B Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Merck USD 26.94B 1.38B Mar/2026
Nestle CHF 40.69B 6.13B Dec/2025
Pacira USD 108.79M 11.8M Mar/2026
Perrigo USD 997.6M 15.3M Mar/2026
Pfizer USD 34.35B 2.64B Mar/2026
Phibro Animal Health USD 281.87M 500K Mar/2026
Prestige Brands USD 120.92M 18.63M Mar/2026
Reckitt Benckiser GBP 7.94B 901M Dec/2024
Sanofi EUR 30.01B 1.66B Mar/2026
Supernus Pharmaceuticals USD 373.93M 35.76M Mar/2026
Teva Pharmaceutical Industries USD 13.53B 76M Mar/2026
Xeris Pharmaceuticals USD 118.59M 9.02M Mar/2026
Zoetis USD 2.05B 182M Mar/2026